Literature DB >> 22136853

Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity.

Chi-Iou Lin1, Justine A Barletta, Matthew A Nehs, Zachary S Morris, David B Donner, Edward E Whang, Jae-wook Jeong, Shioko Kimura, Francis D Moore, Daniel T Ruan.   

Abstract

BACKGROUND: Mitogen-inducible gene 6 (Mig-6) is a putative tumor suppressor gene and prognostic biomarker in papillary thyroid cancer. We hypothesized that Mig-6 knockout would activate pro-oncogenic signaling in mouse thyrocytes.
METHODS: We performed a thyroid-specific knockout using the Cre/loxP recombinase system.
RESULTS: Four knockout and 4 control mouse thyroids were harvested at 2 months of age. Immunoblotting confirmed Mig-6 ablation in knockout mice thyrocytes. Epidermal growth factor receptor (EGFR) and extracellular signal-regulated kinase (ERK) phosphorylation levels were increased in Mig-6 knockout compared to wild-type mice. Total EGFR levels were similar in knockout and wild-type mice. However, EGFR was absent in the caveolae-containing membrane fraction of knockout mice, indicating that Mig-6 depletion is associated with a change in the membrane distribution of EGFR. Although p65 localized to the nucleus in wild-type mice, it was distributed in both cytoplasm and nucleus in knockouts, suggesting that Mig-6 loss decreases p65 activity.
CONCLUSION: Our results confirm the feasibility of targeted, thyroid-specific gene knockout as a strategy for studying the relevance of specific genes in thyroid oncogenesis. We suggest that the loss of Mig-6 alters the membrane distribution of EGFR, which may limit receptor degradation and activate this oncogenic signaling pathway.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22136853      PMCID: PMC3486728          DOI: 10.1016/j.surg.2011.09.014

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  25 in total

1.  Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors.

Authors:  K L Pierce; S Maudsley; Y Daaka; L M Luttrell; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Mig-6 is a negative regulator of the epidermal growth factor receptor signal.

Authors:  P O Hackel; M Gishizky; A Ullrich
Journal:  Biol Chem       Date:  2001-12       Impact factor: 3.915

3.  A novel mechanism of nuclear factor kappaB activation through the binding between inhibitor of nuclear factor-kappaBalpha and the processed NH(2)-terminal region of Mig-6.

Authors:  Toshiyuki Tsunoda; Junichi Inokuchi; Iwai Baba; Koji Okumura; Seiji Naito; Takehiko Sasazuki; Senji Shirasawa
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

4.  Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer.

Authors:  Chi-Iou Lin; Jinyan Du; Wen T Shen; Edward E Whang; David B Donner; Nick Griff; Frank He; Francis D Moore; Orlo H Clark; Daniel T Ruan
Journal:  J Clin Endocrinol Metab       Date:  2010-12-29       Impact factor: 5.958

5.  Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers.

Authors:  Daniel T Ruan; Robert S Warren; Jacob Moalem; Ki-Wook Chung; Ann C Griffin; Wen Shen; Quan-Yang Duh; Eric Nakakura; David B Donner; Elham Khanafshar; Julie Weng; Orlo H Clark; Electron Kebebew
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

6.  Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation.

Authors:  Sara Sigismund; Elisabetta Argenzio; Daniela Tosoni; Elena Cavallaro; Simona Polo; Pier Paolo Di Fiore
Journal:  Dev Cell       Date:  2008-08       Impact factor: 12.270

7.  Thyrocyte-specific expression of Cre recombinase in transgenic mice.

Authors:  Takashi Kusakabe; Akio Kawaguchi; Rumi Kawaguchi; Lionel Feigenbaum; Shioko Kimura
Journal:  Genesis       Date:  2004-07       Impact factor: 2.487

Review 8.  Minireview: thyrotropin receptor signaling in development and differentiation of the thyroid gland: insights from mouse models and human diseases.

Authors:  Mario De Felice; Maria Pia Postiglione; Roberto Di Lauro
Journal:  Endocrinology       Date:  2004-07-01       Impact factor: 4.736

Review 9.  Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer.

Authors:  Kirstine Roepstorff; Lene Grøvdal; Michael Grandal; Mads Lerdrup; Bo van Deurs
Journal:  Histochem Cell Biol       Date:  2008-02-21       Impact factor: 4.304

Review 10.  Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis.

Authors:  Michael Vibo Grandal; Inger Helene Madshus
Journal:  J Cell Mol Med       Date:  2008-03-04       Impact factor: 5.310

View more
  4 in total

1.  Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.

Authors:  Tapan K Maity; Abhilash Venugopalan; Ilona Linnoila; Constance M Cultraro; Andreas Giannakou; Roxanne Nemati; Xu Zhang; Joshua D Webster; Daniel Ritt; Sarani Ghosal; Heinz Hoschuetzky; R Mark Simpson; Romi Biswas; Katerina Politi; Deborah K Morrison; Harold E Varmus; Udayan Guha
Journal:  Cancer Discov       Date:  2015-03-03       Impact factor: 39.397

2.  Upregulation of mitogen-inducible gene 6 triggers antitumor effect and attenuates progesterone resistance in endometrial carcinoma cells.

Authors:  W Xu; S Zhu; Y Zhou; Y Jin; H Dai; X Wang
Journal:  Cancer Gene Ther       Date:  2015-10-09       Impact factor: 5.987

3.  Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation.

Authors:  Malgorzata Milewska; David Romano; Ana Herrero; Maria Luisa Guerriero; Marc Birtwistle; Franz Quehenberger; Stefan Hatzl; Boris N Kholodenko; Oreste Segatto; Walter Kolch; Armin Zebisch
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

Review 4.  Gene 33/Mig6/ERRFI1, an Adapter Protein with Complex Functions in Cell Biology and Human Diseases.

Authors:  Dazhong Xu; Cen Li
Journal:  Cells       Date:  2021-06-22       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.